Antimicrobial-associated encephalopathy due to ampicillin

Naoya Mizutani1, Tsuneaki Kenzaka1,2

  • 1Department of Internal Medicine Hyogo Prefectural Tamba Medical Center Tamba Hyogo Japan.

Clinical Case Reports
|April 3, 2024
PubMed

Insights

Antimicrobial-associated encephalopathy (AAE) can occur when antibiotics disrupt brain signaling by affecting gamma-aminobutyric acid (GABA) receptors. Consider AAE in patients with new neurological or psychiatric symptoms after starting antibiotics.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Infectious Diseases

Background:

  • Gamma-aminobutyric acid (GABA) is a primary inhibitory neurotransmitter in the central nervous system.
  • GABAergic transmission is crucial for maintaining neurological and psychiatric balance.
  • Certain antimicrobial agents possess molecular structures that mimic GABA.

Observation:

  • The β-lactam ring, a common feature in many antibiotics, shares structural similarities with GABA.
  • This structural mimicry allows β-lactam antibiotics to interact with GABA A receptors.
  • Such interactions can lead to the inhibition of normal GABAergic neurotransmission.

Findings:

  • Inhibition of GABAergic transmission by β-lactam antibiotics can manifest as antimicrobial-associated encephalopathy (AAE).
  • AAE presents with a range of neurological and psychiatric symptoms.
  • The mechanism involves direct interference with inhibitory neurotransmitter receptor function.

Implications:

  • Clinicians should maintain a high index of suspicion for AAE in patients presenting with neurological or psychiatric disturbances post-antimicrobial initiation.
  • Early recognition and consideration of AAE can lead to timely diagnosis and appropriate management.
  • Understanding this mechanism highlights a potential adverse effect of a widely used class of antibiotics.